- $261.42bn
- $288.76bn
- $58.74bn
UK shares rise as softer oil, easing gilt yields lift sentiment
Europe Research Roundup: AstraZeneca, Hensoldt, Sika
AstraZeneca to invest over $1 billion in Massachusetts, boost workforce (updated)
Brief: Astrazeneca Opens Global Strategic R&D Center In Kendall Square, Massachusetts
AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment
AstraZeneca completes equity investment in Summit
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (updated)
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
UK Stocks-Factors to watch on October 2 (updated)
Brief: AstraZeneca & Daiichi Sankyo announce clinical collaboration with Summit Therapeutics
AZ & DS collaboration with Summit for Datroway
Admission of Further Securities to Trading
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Ftse 100 Hits Two: week low as energy stocks slide
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Summit soars after $2 billion investment from AstraZeneca for cancer therapies
FTSE 100 rises as AstraZeneca lifts healthcare sector